GLP-1 agonists and the hidden power of outdoor exercise
A recent report documented something remarkable: Americans on glucagon-like peptide-1 (GLP-1) agonists are falling in love with exercise for the first time. A man who struggled to walk to his mailbox now hikes seven miles a day. A woman who needed a cane ran her first five-kilometer (5K) race. A rock climber went from three workouts a week to five.
These drugs proved what physicians should have said more clearly long …
GLP-1 agonists and the hidden power of outdoor exercise















